SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 408 participants.
Also called NCT05801627
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 408 participants
- Registry
-
NCT05801627
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05801627. Randomized; quadruple masking; primary purpose treatment. Start 2020-05-06 (actual); primary completion 2022-05-24 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- SAL067
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
Record details
- Record id
cardio:ct-nct05801627- Content hash
14fd95d7e6c94530f163e9854fcd84802de447d1d0eb97c30d568d32f770f1b7